This review discusses the role of clinical pharmacology in the development of low-dose aspirin and other antiplatelet agents during the past 30 years, emphasizing the main determinants of several success stories as well as of complete failures in the field.
Patrono, C., Role of Clinical Pharmacology in the Development of Antiplatelet Drugs, <<CLINICAL THERAPEUTICS>>, 2014; 36 (12): 2096-2111. [doi:10.1016/j.clinthera.2014.10.012] [http://hdl.handle.net/10807/63529]
Role of Clinical Pharmacology in the Development of Antiplatelet Drugs
Patrono, Carlo
2014
Abstract
This review discusses the role of clinical pharmacology in the development of low-dose aspirin and other antiplatelet agents during the past 30 years, emphasizing the main determinants of several success stories as well as of complete failures in the field.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
